Demars Financial Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $590K | Sell |
757
-618,761
| -100% | -$482M | 0.23% | 46 |
|
|
2025
Q1 | $750K | Buy |
619,518
+100,654
| +19% | +$122K | 0.02% | 70 |
|
|
2024
Q4 | $672K | Buy |
518,864
+518,192
| +77,112% | +$671K | 0.02% | 69 |
|
|
2024
Q3 | $595K | Buy |
672
+3
| +0.4% | +$2.66K | 0.27% | 36 |
|
|
2024
Q2 | $606K | Sell |
669
-88
| -12% | -$79.7K | 0.29% | 35 |
|
|
2024
Q1 | $589K | Buy |
757
+179
| +31% | +$139K | 0.29% | 38 |
|
|
2023
Q4 | $337K | Hold |
578
| – | – | 0.18% | 51 |
|
|
2023
Q3 | $311K | Hold |
578
| – | – | 0.18% | 63 |
|
|
2023
Q2 | $271K | Buy |
+578
| New | +$271K | 0.15% | 66 |
|